β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 4/10
Monitoring for AI engine activity
In the Engagemii AEO index
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. PI3K and Akt as molecular targets for cancer therapy just got measured.
4/10 means PI3K and Akt as molecular targets for cancer therapy is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
PI3K and Akt as molecular targets for cancer therapy
Industry: Media & Entertainment
cell-signaling-pathways.com1
Structured Data
6
Content Structure
5
Entity Clarity
3
E-E-A-T Signals
5
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for PI3K and Akt as molecular targets for cancer therapy.
Scored by Engagemii on July 6, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/cell-signaling-pathways
Cite this score: Engagemii (2026). "AEO Score for PI3K and Akt as molecular targets for cancer therapy." Retrieved from https://engagemii.com/aeo/brands/cell-signaling-pathways
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform